المؤلفون: Almeman AA; Clinical Pharmacology and Therapeutic Department, College of Medicine, Qassim University (QU), Buraydah, Saudi Arabia., Al Mesned A; Pediatric Cardiology, Prince Sultan Cardiac Center (PSCC), Buraydah, Qassim, Saudi Arabia., Alredaini IA; College of Pharmacy, Qassim University, Buraydah, Saudi Arabia., Alhumaidan RI; Faculty of Medicine, Qassim University, Buraydah, Saudi Arabia., Alharbi SB; Faculty of Medicine, Qassim University, Buraydah, Saudi Arabia., Alassaf FA; Faculty of Medicine, Qassim University, Buraydah, Saudi Arabia., Alharbi SF; Faculty of Medicine, Qassim University, Buraydah, Saudi Arabia., Alharbi SB; College of Pharmacy, Qassim University, Buraydah, Saudi Arabia., Alharbi HM; College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.

المصدر: Cardiovascular & hematological disorders drug targets [Cardiovasc Hematol Disord Drug Targets] 2023; Vol. 23 (2), pp. 122-129.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101269160 Publication Model: Print Cited Medium: Internet ISSN: 2212-4063 (Electronic) Linking ISSN: 1871529X NLM ISO Abbreviation: Cardiovasc Hematol Disord Drug Targets Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/drug therapy , Cardiovascular Agents*/therapeutic use, Humans ; Male ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Female ; Saudi Arabia ; Cross-Sectional Studies ; Tertiary Care Centers ; Surveys and Questionnaires